Wuhan Easy Diagnosis Biomedicine News

Mingde Biotech: Half-year summary of non-operating capital usage and other related capital transactions

Aug 28 12:00 ET

Matilda Biotech: 2024 Semi-Annual Financial Report

Aug 28 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Announcement on the Progress of the Company's Participation in the Establishment of Investment Funds and Related Trades.

Aug 20 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Announcement Regarding Change of Internal Audit Person in Charge

Aug 19 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Announcement on the expiry of the agreement on consistent actions by the actual controller and the change of the actual controller.

Aug 13 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 17 12:00 ET

Wuhan Easy Diagnosis Biomedicine: 2023 Annual General Meeting of Shareholders Legal Opinions

May 17 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Notice of Annual General Meeting of Shareholders

Apr 25 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Internal Control Self-Assessment Report

Apr 25 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Summary table of non-operating capital expenditure and other related capital transactions in 2023

Apr 25 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Notice on amending the “Articles of Association”

Apr 25 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Notice on Using Idle Own Funds for Entrusted Financial Management

Apr 25 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Report on the performance of supervisory duties by the Audit Committee on the 2023 Annual Audit Accounting Firm

Apr 25 12:00 ET

Wuhan Easy Diagnosis Biomedicine: Announcement on the resignation of supervisors and the by-election of new supervisors

Apr 25 12:00 ET

Wuhan Easy Diagnosis Biomedicine: 2023 General Manager Work Report

Apr 25 12:00 ET

Matilda Biotech: Announcement on preparation for asset impairment in 2023

Apr 19 12:00 ET

Mingde Biotech: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders

Mar 18 12:00 ET

Matilda Biotech: Legal Opinion of the 2024 First Shareholders\' Meeting

Mar 18 12:00 ET

Mingde Biotech: Announcement on the shareholding status of the top ten shareholders and the top ten shareholders with unlimited sales conditions on the day of share registration at the shareholders' meeting on share repurchase matters

Mar 14 12:00 ET

Matilda Biotech: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024

Mar 1 11:00 ET